-
Psyched: MDMA On Health Canada's Radar, MindMed Seeks FDA Support For LSD, Numinus Buys Mindspace
Saturday, December 19, 2020 - 10:30am | 987Health Canada Considers MDMA And Psilocybin 'Special Access' Program This week, Health Canada opened a public consultation on its “proposal to restore potential access to restricted drugs through the Special Access Program (SAP).” The SAP allows healthcare professionals to...
-
Psychedelics Company HAVN Debuts On CSE
Wednesday, September 9, 2020 - 1:23pm | 459Havn Life Sciences Inc. (CSE : HAVN), a recently-formed psychedelics company, announced on Tuesday its debut on the Canadian Securities Exchange under the symbol HAVN. The company is led by co-CEOs Susan Chapelle and Tim Moore, the former CEO of cannabis company Green Growth Brands Inc (OTC: GGBXF...
-
Aphria's President To Resign Amid Another Management Reshuffle
Tuesday, May 14, 2019 - 9:14am | 313Aphria Inc (NYSE: APHA) on Tuesday announced some management changes. What Happened Aphria announced its President Jakob Ripshtein will resign from the company June 7. Ripshtein was promoted to the role in November, which gave him the responsibility of the company's operating units worldwide....
-
The CEO Of A Canadian Medical Cannabis Producer Talks Trump, Ontario And Securing A Supply Chain
Saturday, August 18, 2018 - 9:33am | 653By Etan Vlessing President Donald Trump's support of potential legislation to end the federal ban on marijuana in the U.S. is a prelude to American entertainment brands buying up Canadian assets to exploit an inevitable legalized recreational cannabis market south of the border, according...
-
Cannabis After Legalization: Vic Neufeld Shares Aphria's Plan For Growth
Friday, July 13, 2018 - 1:02pm | 1586Cannabis investors can't afford to miss the Benzinga Cannabis Capital Conference, a premier gathering of investors and entrepreneurs painting an honest picture of the opportunities and challenges in cannabis investing. Space is limited—get your tickets before they sell out. Ahead of...